The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
which causes COVID-19, has now spread all over the globe, infected
millions, and already killed more than 150.000 people. Elderly people
are most likely to develop severe disease and to die from COVID-19.
The aim of this project is to have a manufacturable, cost-effective,
ultrapotent SARS-CoV-2-neutralizing antibody ready for ...